When is albumin infusion indicated in a pregnant patient with eclampsia, albuminuria, and edema?

Albumin Infusion is NOT Indicated in Eclampsia with Edema and Albuminuria

Albumin should not be administered to pregnant patients with eclampsia, albuminuria, and edema. The most authoritative guidelines explicitly recommend against this practice, and the available evidence shows no benefit for maternal or fetal outcomes.

Guideline-Based Recommendations

The 2018 ISSHP (International Society for the Study of Hypertension in Pregnancy) guidelines provide clear direction for fluid management in preeclamptic/eclamptic patients 1:

• Fluid restriction is recommended: Total fluid intake should be limited to 60-80 mL/hour during labor and the acute period
• Aim for euvolemia, not volume expansion: Replace insensible losses (30 mL/h) plus anticipated urinary losses (0.5-1 mL/kg/hour)
• Avoid pulmonary edema risk: There is "no rationale to 'run dry' a preeclamptic woman as she is already at risk of AKI," but equally important is avoiding fluid overload 1

The 2024 ICTMG albumin guidelines further reinforce this by stating that in critically ill adult patients, intravenous albumin in conjunction with diuretics is not suggested for removal of extravascular fluid (Conditional Recommendation, Very Low Certainty of Evidence) 2.

Why Albumin Doesn't Work in This Setting

Research evidence demonstrates that albumin infusion in preeclampsia:

• Does not lower blood pressure 3
• Does not improve uteroplacental or fetoplacental blood flow in a sustained manner 3
• Does not produce stable changes in renal function 3
• Does not reduce the need for antihypertensive therapy 3

The pathophysiology explains why: preeclamptic patients have capillary leak syndrome. Infused albumin rapidly extravasates into the interstitial space, potentially worsening edema rather than improving it. The albuminuria itself reflects glomerular endothelial dysfunction, not simple hypovolemia.

What Should Be Done Instead

For eclampsia management, the priorities are:

1. Magnesium sulfate for seizure prophylaxis/treatment (loading dose 4-6g IV, then maintenance) 1
2. Blood pressure control with IV labetalol, hydralazine, or oral nifedipine when BP ≥160/110 mmHg 1
3. Judicious fluid management at 60-80 mL/hour to maintain euvolemia 1
4. Delivery planning as the definitive treatment

Critical Caveats

The presence of edema and albuminuria in eclampsia does NOT indicate hypovolemia requiring albumin. These are manifestations of the disease process itself (endothelial dysfunction and capillary leak), not volume depletion.

The FDA labeling for albumin does mention "hypoproteinemia with or without edema" as a potential indication 4, but this is in the context of surgical protein losses or other specific conditions—not preeclampsia/eclampsia. The FDA precautions explicitly warn that "in the presence of dehydration, albumin must be given with or followed by addition of fluids" 4, and hyperoncotic albumin (25%) can actually worsen the situation by drawing fluid from already compromised interstitial spaces.

Avoid the common pitfall of thinking that low serum albumin + edema = indication for albumin infusion. In preeclampsia/eclampsia, this combination reflects capillary leak, and albumin will simply leak out as well, providing no therapeutic benefit while risking circulatory overload and pulmonary edema 1.

The only potential exception would be massive hemorrhage requiring volume resuscitation, but even then, crystalloids or blood products would be preferred over albumin 2.